PS
Puneet Souda Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Quanterix
QTRX
$199M
| $4.29 | $15 |
250%
upside
| Market Perform |
9 Nov ‘22
2 years ago |
|
27
NeoGenomics
NEO
$1.02B
| $7.86 | $15 |
91%
upside
| Outperform |
9 Nov ‘22
2 years ago |
|
28
Veracyte
VCYT
$2.55B
| $31.99 | $35 |
9%
upside
| Outperform |
3 Nov ‘22
2 years ago |
|
29
Myriad Genetics
MYGN
$643M
| $6.97 | $25 |
259%
upside
| Market Perform |
2 Nov ‘22
2 years ago |
|
30
Castle Biosciences
CSTL
$698M
| $24.65 | $50 |
103%
upside
| Market Outperform |
9 Aug ‘22
3 years ago |
|
31
Bruker
BRKR
$4.73B
| $31.18 | $87 |
179%
upside
| Outperform |
5 May ‘22
3 years ago |
|
32
Guardant Health
GH
$7.41B
| $59.44 | $140 |
136%
upside
| Outperform |
24 Feb ‘22
3 years ago |
|
33
Natera
NTRA
$24.2B
| $176.37 | $160 |
9%
downside
| Outperform |
22 Jun ‘21
4 years ago |
|